Skip to Content

Sample Issues

If you like what you read, subscribe to The Medical Letter to ensure your access to this unbiased source of drug information.

To read these articles you will need a free Adobe® Reader.

The Medical Letter on Drugs and Therapeutics
July 21, 2014 (Issue 1447)
  • In Brief: Generic Celecoxib
  • Extended-Release Oxycodone and Acetaminophen (Xartemis XR)
  • Oral Propranolol (Hemangeol) for Infantile Hemangioma
  • Ceritinib (Zykadia) for Non-Small Cell Lung Cancer
  • A Responsive Neurostimulator Device (RNS System) for Epilepsy
  • In Brief: Esomeprazole Strontium
  • In Brief: Low-Dose Indomethacin (Tivorbex) for Pain

Canadian-Adapted Version: July 21, 2014 (Issue 1447)
  • In Brief: Generic Celecoxib
  • Extended-Release Oxycodone and Acetaminophen (Xartemis XR)
  • Oral Propranolol (Hemangeol) for Infantile Hemangioma
  • Ceritinib (Zykadia) for Non-Small Cell Lung Cancer
  • A Responsive Neurostimulator Device (RNS System) for Epilepsy
  • In Brief: Esomeprazole Strontium
  • In Brief: Low-Dose Indomethacin (Tivorbex) for Pain

French Canadian Version: 18 août 2014 (ML 1447)
  • En bref : Célécoxib générique
  • Oxycodone à libération prolongée et acétaminophène (Xartemis XR)
  • Propranolol oral (Hemangeol) contre l’hémangiome infantile
  • Céritinib (Zykadia) contre le cancer du poumon non à petites cellules
  • Un dispositif de neurostimulation réponse (RNS System) pour traiter l’épilepsie
  • En bref : Esoméprazole strontium
  • En bref : Indométacine à faible dose (Tivorbex) contre la douleur

Subscribe for immediate online access